4/3
04:10 pm
aeon
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Low
Report
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
4/3
04:05 pm
aeon
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
Low
Report
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
3/30
04:05 pm
aeon
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program
Low
Report
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program
3/25
08:00 am
aeon
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
Low
Report
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
3/9
04:05 pm
aeon
AEON Biopharma Appoints John Bencich as Chief Financial Officer
Medium
Report
AEON Biopharma Appoints John Bencich as Chief Financial Officer
3/5
04:05 pm
aeon
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
Low
Report
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
1/21
04:05 pm
aeon
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
High
Report
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions